Business Segments · Provision for income taxes
Business Segments — Provision for income taxes
Vertex Pharmaceuticals Business Segments — Provision for income taxes increased by 58.3% to $221.5M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 163.4%, from $84.1M to $221.5M. Over 3 years (FY 2022 to FY 2025), Business Segments — Provision for income taxes shows a downward trend with a -8.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026
Rolls up toIncome Tax
How to read this metric
Changes reflect fluctuations in pre-tax profitability or shifts in the effective tax rate due to jurisdictional changes.
Detailed definition
The estimated tax expense calculated on the company's pre-tax earnings based on applicable tax jurisdictions. This refle...
Peer comparison
Standardized as 'Provision for Income Taxes' on the income statement.
Metric ID:
vrtx_segment_pharmaceuticals_provision_for_income_taxesHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $227.6M | $227.6M | $227.6M | $227.6M | $190.05M | $190.05M | $190.05M | $190.05M | $179.5M | $202.4M | $178.7M | $223.5M | $84.1M | $250.1M | $215.9M | $139.9M | $221.5M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -16.5% | +0.0% | +0.0% | +0.0% | -5.6% | +12.8% | -11.7% | +25.1% | -62.4% | +197.4% | -13.7% | -35.2% | +58.3% |
| YoY Change | — | — | — | — | -16.5% | -16.5% | -16.5% | -16.5% | -5.6% | +6.5% | -6.0% | +17.6% | -53.1% | +23.6% | +20.8% | -37.4% | +163.4% |
Range$84.1M – $250.1M
CAGR-0.7%
Avg YoY Growth+4.9%
Median YoY Growth-6.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's business segments — provision for income taxes?
- Vertex Pharmaceuticals (VRTX) reported business segments — provision for income taxes of $221.5M in Q1 2026.
- How has Vertex Pharmaceuticals's business segments — provision for income taxes changed year-over-year?
- Vertex Pharmaceuticals's business segments — provision for income taxes increased by 163.4% year-over-year, from $84.1M to $221.5M.
- What is the long-term trend for Vertex Pharmaceuticals's business segments — provision for income taxes?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's business segments — provision for income taxes has grown at a -8.8% compound annual growth rate (CAGR), from $910.4M to $690M.
- What does business segments — provision for income taxes mean?
- The amount of money the company sets aside to pay income taxes.